Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors: concise report of a qualitative study.

Maria Ntessalen; Sajan  McCorkindale; Albana Krasniqi; Heather Morgan; Julia Allan; Peter Murchie

doi:10.1093/ced/llad279

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors: concise report of a qualitative study.

Maria Ntessalen, Sajan McCorkindale, Albana Krasniqi, Heather Morgan, Julia Allan, Peter Murchie^* (Corresponding Author)

^*Corresponding author for this work

University of Aberdeen

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Abstract

We developed the Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma app to support monthly total-skin-self-examinations (TSSE) by melanoma survivors. A randomized 12-month trial demonstrated ASICA supported optimal monthly TSSE adherence in one third of participants. However, a further third of participants adhered well initially but subsequently dropped off, and a final third did not adhere at all. This follow-up qualitative study investigated trial participants’ perceptions of barriers and facilitators to TSSE adherence using the app. Three former trial participants participated in a single focus group and 11 participated in new semi-structured telephone interviews. These were analysed thematically alongside secondary analysis of 12 qualitative interviews conducted during the trial. All transcripts were recorded, transcribed, and analysed thematically. Five themes encompassing barriers and
facilitators to ASICA adherence emerged. These were: technology; role of others; tailoring; disease journey, and competing priorities. These data will inform further development of ASICA to increase user-adherence.

Original language	English
Pages (from-to)	1358-1360
Number of pages	3
Journal	Clinical and Experimental Dermatology
Volume	48
Issue number	12
Early online date	23 Aug 2023
DOIs	https://doi.org/10.1093/ced/llad279
Publication status	Published - Dec 2023

Bibliographical note

Open Access via the OUP Agreement
Funding source: This study was funded by a grant from Cancer Research UK (Project
Number C10673/A21685)
Acknowledgements:
The authors gratefully acknowledge the time and commitment of those patient participants who gave their time to be interviewed in the study. We also acknowledge the contribution of Billy Brant, Dermatology Nurse Practitioner, NHS Grampian, to the day to day running of the study. We acknowledge the support of Andrea Fraser of the ASICA trial team from the Centre of Healthcare Randomized Trials (CHaRT) at the University of Aberdeen. We also acknowledge Hazel Riley who transcribed the interviews for analysis.

Data Availability Statement

The data underlying this article are available upon request from the corresponding author.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ced/llad279Licence: CC BY

Ntessalen_etal_CED_Barriers_And_Facilitators_AAM
This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical and Experimental Dermatology following peer review. The version of record [insert complete citation information here] will be available online at: https://doi.org/10.1093/ced/llad279 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Accepted author manuscript, 120 KBLicence: CC BY
Ntessalen_etal_CED_Barriers_and_Facilitators_VOR
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Final published version, 518 KBLicence: CC BY

Cite this

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors: concise report of a qualitative study. . / Ntessalen, Maria; McCorkindale, Sajan ; Krasniqi, Albana et al.
In: Clinical and Experimental Dermatology, Vol. 48, No. 12, 12.2023, p. 1358-1360.

Research output: Contribution to journal › Article › peer-review

@article{12a27cbe61f743b6b4f6009a4f35ae3c,

title = "Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors: concise report of a qualitative study. ",

abstract = "We developed the Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma app to support monthly total-skin-self-examinations (TSSE) by melanoma survivors. A randomized 12-month trial demonstrated ASICA supported optimal monthly TSSE adherence in one third of participants. However, a further third of participants adhered well initially but subsequently dropped off, and a final third did not adhere at all. This follow-up qualitative study investigated trial participants{\textquoteright} perceptions of barriers and facilitators to TSSE adherence using the app. Three former trial participants participated in a single focus group and 11 participated in new semi-structured telephone interviews. These were analysed thematically alongside secondary analysis of 12 qualitative interviews conducted during the trial. All transcripts were recorded, transcribed, and analysed thematically. Five themes encompassing barriers andfacilitators to ASICA adherence emerged. These were: technology; role of others; tailoring; disease journey, and competing priorities. These data will inform further development of ASICA to increase user-adherence.",

author = "Maria Ntessalen and Sajan McCorkindale and Albana Krasniqi and Heather Morgan and Julia Allan and Peter Murchie",

note = "Open Access via the OUP Agreement Funding source: This study was funded by a grant from Cancer Research UK (Project Number C10673/A21685) Acknowledgements: The authors gratefully acknowledge the time and commitment of those patient participants who gave their time to be interviewed in the study. We also acknowledge the contribution of Billy Brant, Dermatology Nurse Practitioner, NHS Grampian, to the day to day running of the study. We acknowledge the support of Andrea Fraser of the ASICA trial team from the Centre of Healthcare Randomized Trials (CHaRT) at the University of Aberdeen. We also acknowledge Hazel Riley who transcribed the interviews for analysis. ",

year = "2023",

month = dec,

doi = "10.1093/ced/llad279",

language = "English",

volume = "48",

pages = "1358--1360",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Oxford University Press (OUP)",

number = "12",

}

TY - JOUR

T1 - Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors

T2 - concise report of a qualitative study.

AU - Ntessalen, Maria

AU - McCorkindale, Sajan

AU - Krasniqi, Albana

AU - Morgan, Heather

AU - Allan, Julia

AU - Murchie, Peter

N1 - Open Access via the OUP Agreement Funding source: This study was funded by a grant from Cancer Research UK (Project Number C10673/A21685) Acknowledgements: The authors gratefully acknowledge the time and commitment of those patient participants who gave their time to be interviewed in the study. We also acknowledge the contribution of Billy Brant, Dermatology Nurse Practitioner, NHS Grampian, to the day to day running of the study. We acknowledge the support of Andrea Fraser of the ASICA trial team from the Centre of Healthcare Randomized Trials (CHaRT) at the University of Aberdeen. We also acknowledge Hazel Riley who transcribed the interviews for analysis.

PY - 2023/12

Y1 - 2023/12

N2 - We developed the Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma app to support monthly total-skin-self-examinations (TSSE) by melanoma survivors. A randomized 12-month trial demonstrated ASICA supported optimal monthly TSSE adherence in one third of participants. However, a further third of participants adhered well initially but subsequently dropped off, and a final third did not adhere at all. This follow-up qualitative study investigated trial participants’ perceptions of barriers and facilitators to TSSE adherence using the app. Three former trial participants participated in a single focus group and 11 participated in new semi-structured telephone interviews. These were analysed thematically alongside secondary analysis of 12 qualitative interviews conducted during the trial. All transcripts were recorded, transcribed, and analysed thematically. Five themes encompassing barriers andfacilitators to ASICA adherence emerged. These were: technology; role of others; tailoring; disease journey, and competing priorities. These data will inform further development of ASICA to increase user-adherence.

AB - We developed the Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma app to support monthly total-skin-self-examinations (TSSE) by melanoma survivors. A randomized 12-month trial demonstrated ASICA supported optimal monthly TSSE adherence in one third of participants. However, a further third of participants adhered well initially but subsequently dropped off, and a final third did not adhere at all. This follow-up qualitative study investigated trial participants’ perceptions of barriers and facilitators to TSSE adherence using the app. Three former trial participants participated in a single focus group and 11 participated in new semi-structured telephone interviews. These were analysed thematically alongside secondary analysis of 12 qualitative interviews conducted during the trial. All transcripts were recorded, transcribed, and analysed thematically. Five themes encompassing barriers andfacilitators to ASICA adherence emerged. These were: technology; role of others; tailoring; disease journey, and competing priorities. These data will inform further development of ASICA to increase user-adherence.

U2 - 10.1093/ced/llad279

DO - 10.1093/ced/llad279

M3 - Article

SN - 0307-6938

VL - 48

SP - 1358

EP - 1360

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 12

ER -

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support melanoma survivors: concise report of a qualitative study.

Abstract

Bibliographical note

Data Availability Statement

UN SDGs

Access to Document

Fingerprint

Cite this